281-290 of 350 results
When trade mark law gets Messi, better call the Dr (Dre)
Having a famous name has many perks, and as Lionel Messi recently found out, registering your name as a trade mark is one of these. However, such fame is a double-edged sword, as Dr Dre recently experienced. ...
Fishing at one's discretion – Trident Seafoods Corporation v Trident Foods Pty Limited
In a dispute over the 'Trident' trade mark, Justice Gleeson considered that the residual reputation a subsidary held over its parent company warranted the mark remaining on the Register. ...
EU leads the way with counterfeit crackdown
The European Commission has recently established the world's first counterfeit and piracy watch list, which aims to crack down on counterfeiting and piracy both within the European Union and in external suspect markets. Partner Tim Golder and Vacation Clerk Scott Sidley report. ...
Red letter day for Louboutin – Frucor green with envy
Two recent decisions provide mixed news for the owners of colour trade marks ...
Report: Proposed changes to the Australian Patents Act, and how they will affect you
This Insight discusses draft legislation proposing further changes to the Australian Patents Act in response to the Productivity Commissions recent inquiry into Australia's IP arrangement. ...
Global trade mark update
There have been significant, and proposed, trade mark law developments across the globe which are likely to inform trade mark portfolio strategy. ...
Licence to infringe: Patent Office grants Sandoz licence to exploit Lexapro® patent
In the latest chapter of one the longest-running sagas in Australian patent litigation history, the Deputy Commissioner of Patents has retrospectively granted Sandoz a licence to exploit Lundbeck's patent for its blockbuster antidepressant Lexapro® (escitalopram). The licence, only the second of its kind to be granted in Australia, provides Sandoz with a defence to Lundbeck's multi-million dollar infringement claim. ...
No relief in PBS price changes for originators seeking injunctions
Patentees may face heightened risks when changes to the Pharmaceutical Benefits Scheme (PBS) take effect later this year. Special Counsel Ric Morgan and Associate Claire Gregg explain. ...
What you need to know about mandatory data breach notification
In response to the rising number of cyberattacks, new legislation has been introduced that proposes a mandatory notification regime that will take effect from February next year. ...
Nurofen maker in need of fast pain relief
Paracetamol manufacturer Hence Reckitt Benckiser has discovered that inaccurate and unbalanced comparative claims that don't reflect the overall picture can cause big headaches, even where those claims have some support. ...